SynthesisDiabetes, obesity & metabolism2017
Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment.
Markolf Hanefeld et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled ittrialcites it